Collectively, we concluded that CX3CL1 could induce NSCLC cell transendothelial migration by increasing the permeability of VBMECs via ICAM-1-dependent activation of the Src/GEF-H1 pathway. The gene discussed is CX3CL1; the disease is non-small cell lung carcinoma.